The Impact of Secondhand Smoke Exposure on the Incidence of Bronchopneumonia in Toddlers: A Case Report

Authors

  • Ahmad Fathin Al Farisi universitas lampung
  • Shinta Nareswari

DOI:

https://doi.org/10.53089/medula.v17i1.1985

Keywords:

Bronchopneumonia, children, Streptococcus pneumoniae

Abstract

Bronchopneumonia is a lower respiratory tract infection that remains a major cause of morbidity and mortality among children, particularly toddlers. Exposure to environmental tobacco smoke has been recognized as an important risk factor that increases children's susceptibility to respiratory infections. This case report aims to describe the impact of secondhand smoke exposure on the occurrence of bronchopneumonia in a toddler. A 1.5-year-old boy presented with a six-day history of productive cough with thick green sputum, shortness of breath, and fever. The diagnosis was established based on medical history, physical examination such as takipneu and subcostal retraction, laboratory investigations, and chest radiography, which revealed bilateral patchy perihilar infiltrates. Exposure to cigarette smoke from his father, an active smoker, was identified as the primary risk factor. Management consisted of intravenous Ringer’s lactate fluid therapy, intravenous ampicillin, and oral paracetamol. After five days of treatment, the patient demonstrated significant clinical improvement and was discharged for outpatient follow-up. Secondhand smoke exposure is thought to contribute to the pathogenesis of bronchopneumonia by impairing mucociliary clearance, increasing mucus production, and suppressing local immune responses, thereby facilitating bacterial colonization of the lower respiratory tract. This case highlights that the harmful effects of cigarette smoke exposure may outweigh the protective benefits of good nutritional status, exclusive breastfeeding, and complete immunization. Therefore, education regarding the dangers of secondhand smoke exposure and smoking cessation within the household is essential for preventing recurrent bronchopneumonia in children.

Author Biographies

Ahmad Fathin Al Farisi, universitas lampung

 

 

Shinta Nareswari

 

 

References

Zhang L. To observe the effect of acetylcysteine combined with diphylline on pulmonary function and inflammatory response in children with bronchopneumonia. Pakistan journal of pharmacy sciences. 2025;38(4):1117–1124.

Saatirah ZY, Arfah AI, Darussalama AHE, Jafar MA, Wahyu S. Characteristic of Bronchopneumonia in Children at Dr. Abdul Rivai Regency Hospital, Berau District, East Kalimantan Province in 2022-2023. Jurnal Eduhealth. 2025;16(01):734-735.

Kong T, Wang J, Chen C. A Promising Candidate in the Treatment of Children with Bronchopneumonia: Erythromycin Plus PIP/TAZ. Alternative therapies in health and medicine. 2024;AT9966.

Zade A, Akhuj A, Lalwani L, Jhunjhunwala S, Daf RV. Physiotherapy Approach for Treating Bronchopneumonia: A Case Report. Cureus. 2023;15(12):e51246.

Ahn J, Cho H, Li D, dkk. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: A systematic review and meta-analysis. BMC Infectious Diseases. 2021;21(1):1003.

Zhang L, Cao L, Meng L. Pathogenic changes of community-acquired pneumonia in a children's hospital in Beijing, China before and after COVID-19 onset: A retrospective study. World Journal of Pediatrics. 2022;18(11):746–752.

Yang H. Benefits and risks of therapeutic alternatives for macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Korean Journal of Pediatrics. 2019;62(6):199–205.

Mackenzie G. The definition and classification of pneumonia. Pneumonia (Nathan Qld.). 2016;8:14.

Jain V, Vashisht R, Yilmaz G, Bhardwaj A. Pneumonia pathology [internet]. Treasure Island (FL): StatPearls Publishing; 2025 [diperbarui tanggal 11 Feb 2025; disitasi tanggal 9 Juni 2026]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK526116/

Ebeledike C, Ahmad T. Pediatric pneumonia [internet]. Treasure Island (FL): StatPearls Publishing; 2025 [diperbarui tanggal 16 Jan 2023; disitasi tanggal 9 Juni 2026]. Tersedia dari: https://www.ncbi.nlm.nih.gov/books/NBK536940/

Matera MG, Rogliani P, Ora J, Cazzola M. Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents. Expert Opin Pharmacother. 2018;19(18):2043-2053.

Jones LL, Hashim A, McKeever T, Cook DG, Britton J, Leonardi-Bee J. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respiratory Research. 2011;12:5.

Li Y, Niu Y, Duan Z, dkk. Global burden of lower respiratory infections attributable to secondhand smoke among children under 5 years of age, 2010–2019. BMC Public Health. 2023;23:2200.

Khujaefah, Prayogo I. The association between passive smoke exposure and the incidence of pneumonia in children under five: a systematic review. International Journal of Medical Science and Health Research. 2025.

Merianos AL, Dixon CA, Mahabee-Gittens EM, et al. Secondhand Smoke Exposure and Illness Severity Among Children Hospitalized with Pneumonia. J Pediatr. 2015;167(4):869–874.

Published

2026-06-23

How to Cite

Al Farisi, A. F. ., & Nareswari, S. (2026). The Impact of Secondhand Smoke Exposure on the Incidence of Bronchopneumonia in Toddlers: A Case Report. Medical Profession Journal of Lampung, 17(1), 45-51. https://doi.org/10.53089/medula.v17i1.1985

Issue

Section

Artikel